Q2 2025 Management View Joseph Michael Burnett, CEO, described 2025 as the start of ClearPoint Neuro’s “third phase,” called Fast. Forward., emphasizing an expanded commitment to cell and gene therapy ...

DermaKleen, Dermasarra, Kleenfoam, and PeriGiene soaps and lotions have been recalled for bacterial contamination that could ...

The U.S. Food and Drug Administration has approved Insmed's oral drug for a type of lung disease, the company said on Tuesday ...

A unanimous panel, including the FDA commissioner, says the black box warnings are outdated and need to be removed by the FDA ...

DermaRite Industries, LLC has issued a nationwide recall of several soap products after detecting contamination with ...

The family members of the victim said they were never told their loved one died due to the outbreak, their lawyer, Bill Marler, said.

One popular health platforms is promoting GLP-1 microdosing for weight loss: But how safe and effective is this approach?

We need to rebuild the trust together,” Susan Monarez said Tuesday, just days after a shooter fired close to 200 rounds that ...

The FDA granted approval to brensocatib for treating adults and children aged at least 12 years with non-cystic fibrosis ...

Parents in the United States who want to vaccinate their young children against Covid-19 this fall may face a growing set of ...

Catalyst Pharmaceuticals stock shines with FIRDAPSE & AGAMREE growth. Learn why the biopharma name is cheap enough to start ...

IO Biotech's phase 3 melanoma trial showed a strong PFS benefit, especially in true 1st-line and PD1-negative patients. Click ...